Platelet Rich Plasma Market to Surpass US$ 1,129.4 Million by 2030, Says Coherent Market Insights (CMI)

Burlingame, Feb. 27, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global platelet rich plasma market is estimated to be valued at US$ 442.7 million in 2022 and is expected to exhibit a CAGR of 12.4% during the forecast period (2022-2030).

Key Trends and Analysis of the Global Platelet Rich Plasma Market:

Major players operating in the market are focusing on product launches which is expected to drive the growth of global platelet rich plasma market over the forecast period. For instance, on September 13, 2022, SUNEVA MEDICAL, an innovative medical technology company, launched 30 mL iteration of their Amplifine Platelet Rich Plasma (PRP) gel tubes. This gel is designed to capture high concentration of platelets in low clearing time which will deliver clinical benefits to the patient.

Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/936

Platelet Rich Plasma Market Report Coverage

Key Market Takeaways:

The platelet rich plasma market is expected to exhibit a CAGR of 12.4% during the forecast period due to research & development in drug delivery system for platelet rich plasma-derived bioactive molecules. For instance, in September 2020, researchers from Institute of Experimental Medicine of the Czech Academy of Sciences and Charles University, Czech Republic, reported development of a simple delivery system to prolong the effects of the bioactive molecules released from platelets.

Among type, pure platelet rich plasma segment is expected to hold the dominant position, owing to the new approvals by regulatory agency. For instance, on December 1, 2019, EmCyte manufacturer of platelet rich plasma and progenitor stem cell biologics, announced that it has received U.S. food and drug association 510(k) clearance for its Progenikine Concentrating System for adipose lipoplasty. This system is designed for pure extraction centrifugation of adipose concentrates.

On the basis of applications, orthopedic surgery segment is expected to hold a dominant position over the forecast period, owning to increasing prevalence of orthopedic conditions. For instance, on August 28, 2022, an article published in cureus journal stated that Platelet-wealthy plasma (PRP) is a promising remedy alternative for more than one orthopedic conditions, which has confirmed increasing scientific use. With improved scientific use of PRP, there was an extra demand for point-of-care (POC) biologic devices.

Competitive Landscape:

Key players operating in the global platelet rich plasma market include Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, Estar Technologies Ltd., Dr. PRP America, Cesca Therapeutics, Inc., Arteriocyte Medical Systems, Harvest Technologies Corp.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/936

Market Segmentation:

• Global Platelet Rich Plasma Market, By Type:
  • Pure PRP
  • Leukocyte rich PRP
  • Pure PRF
  • Leukocyte rich PRF
• Global Platelet Rich Plasma Market, By Origin:
  • Autologous
  • Allogenic
  • Homologues
• Global Platelet Rich Plasma Market, By Application:
  • Neurosurgery
  • Cosmetic Surgery
  • Orthopedic Surgery
  • General Surgery
  • Others
• Global Platelet Rich Plasma Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Region/Country
      • South Africa
      • Central Africa
      • North Africa

Related Market Intelligence Reports:

Bovine Plasma Market, by Grade (Technical and Standard), by Origin (U.S., Australia, New Zealand, and Others (Brazil, Mexico, etc.)), by Application (Cell Culture Media, Vaccine Production, Drug Discovery, and Others (Forensic Studies, in vitro diagnostics, etc.)), by End User (Biopharmaceutical Industry, Academic & Research Institutes, and Others (Diagnostic Laboratories, Forensic Laboratories, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

Orthopedic Regenerative Medicine Market, by Treatment Type (Stem Cell Therapy (Allogeneic Bones, Autogeneic Bones, and Bone Grafting), Plasma Based Therapy, Tissue Engineering (Allograft)), by Disease Indication (Osteoarticular Diseases, Rheumatoid Arthritis, Ligament Injuries, Bursitis, and Osteoporosis), by End User (Hospital and Clinics, Orthopedic Specialty Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Follow Us: LinkedIn | Twitter